All AbMole products are for research use only, cannot be used for human consumption.
JD-5037 is a cannabinoid-1 receptor blocker (CB1R antagonist) with IC50 of 1.5 nM. JD-5037 is very selective for the CB1 subtype, with a Ki of 0.35nM, >700-fold higher affinity than it has for CB2 receptors. In vivo, JD5037 (3 mg/kg/d, i.p.) induces equal reductions in body weight, attenuates the HFD-induced hyperglycemia, and reduces the HFD-induced hepatic injury and steatosis in obese Magel2-null mice. JD5037 (3 mg/kg/day, p.o.) significantly reduces the size of tumors and abrogates the tumor in DEN-treated mice.
| Molecular Weight | 572.51 |
| Formula | C27H27Cl2N5O3S |
| CAS Number | 1392116-14-1 |
| Solubility (25°C) | DMSO ≥ 90 mg/mL |
| Storage |
Powder -20°C 3 years ; 4°C 2 years In solvent -80°C 6 months ; -20°C 1 month |
[3] Robert J Chorvat, et al. Bioorg Med Chem Lett. Peripherally restricted CB1 receptor blockers
| Related Cannabinoid Products |
|---|
| Org 27569
Org 27569 is a potent and selective allosteric modulator of the cannabinoid CB1 receptor. |
| AM1241
AM1241 is a cannabinoid CB2 receptor selective agonist. |
| CP 945598 hydrochloride
CP 945598 hydrochloride is a selective and high affinity CB1 antagonist (Ki values are 0.7 and 0.12 nM in binding and functional assays respectively). |
| AM-2201
AM-2201 is a potent synthetic cannabinoid (CB) with Ki values of 1.0 and 2.6 nM for the CB1 and CB2 receptors, respectively. |
| AM251
AM251 block the inhibitory effects of endocannabinoids and synthetic cannabinoid agonists on transmitter release through an action at presynaptic cannabinoid 1 receptors in brain. |
All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.
